HU0202114D0 - - Google Patents

Info

Publication number
HU0202114D0
HU0202114D0 HU0202114A HUP0202114A HU0202114D0 HU 0202114 D0 HU0202114 D0 HU 0202114D0 HU 0202114 A HU0202114 A HU 0202114A HU P0202114 A HUP0202114 A HU P0202114A HU 0202114 D0 HU0202114 D0 HU 0202114D0
Authority
HU
Hungary
Application number
HU0202114A
Other languages
Hungarian (hu)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0202114D0 publication Critical patent/HU0202114D0/hu
Publication of HUP0202114A2 publication Critical patent/HUP0202114A2/hu
Publication of HUP0202114A3 publication Critical patent/HUP0202114A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0202114A 2001-06-28 2002-06-27 Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines HUP0202114A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30171201P 2001-06-28 2001-06-28
US32825401P 2001-10-10 2001-10-10

Publications (3)

Publication Number Publication Date
HU0202114D0 true HU0202114D0 (cg-RX-API-DMAC7.html) 2002-09-28
HUP0202114A2 HUP0202114A2 (hu) 2003-01-28
HUP0202114A3 HUP0202114A3 (en) 2004-07-28

Family

ID=26972559

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202114A HUP0202114A3 (en) 2001-06-28 2002-06-27 Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines

Country Status (12)

Country Link
EP (1) EP1270000A3 (cg-RX-API-DMAC7.html)
JP (1) JP2003034638A (cg-RX-API-DMAC7.html)
KR (1) KR20030015828A (cg-RX-API-DMAC7.html)
CN (1) CN1394602A (cg-RX-API-DMAC7.html)
AU (1) AU4239302A (cg-RX-API-DMAC7.html)
CA (1) CA2391205A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022076A3 (cg-RX-API-DMAC7.html)
HK (1) HK1049795A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0202114A3 (cg-RX-API-DMAC7.html)
IL (1) IL150340A0 (cg-RX-API-DMAC7.html)
PL (1) PL354770A1 (cg-RX-API-DMAC7.html)
SK (1) SK8682002A3 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476934B2 (ja) * 2003-04-14 2010-06-09 明治乳業株式会社 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法
JP2008506768A (ja) * 2004-07-22 2008-03-06 ファルマシア コーポレーション Cox−2選択的阻害剤とltb4受容体アンタゴニストを組み合わせて用いる炎症および疼痛を治療するための組成物
PT1888033E (pt) * 2005-06-09 2014-05-15 Meda Ab Método e composição para tratamento de distúrbios inflamatórios
EP3383389B1 (en) * 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
WO2017095722A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
DE4228200A1 (de) * 1992-08-25 1994-03-03 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
NZ285156A (en) * 1994-10-13 1999-01-28 Pfizer Benzopyran and benzo-fused compounds, preparation and use as leukotriene b4 antagonists (ltb4)
US5939452A (en) * 1994-10-13 1999-08-17 Pfizer Inc Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
US6342510B1 (en) * 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
YU13299A (sh) * 1996-09-16 2001-03-07 Pfizer Inc. Postupak i intermedijari za dobijanje hromanolnih derivata
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
AU5687199A (en) * 1998-08-24 2000-03-14 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
JP2003225088A (ja) * 1999-09-10 2003-08-12 Meiji Seika Kaisha Ltd ヒト・ロイコトリエンb4第二受容体及びそれをコードするdna
AU3930201A (en) * 2000-03-17 2001-09-24 Bayer Aktiengesellschaft Regulation of human leukotriene B4-like G protein-coupled receptor

Also Published As

Publication number Publication date
HUP0202114A3 (en) 2004-07-28
KR20030015828A (ko) 2003-02-25
HUP0202114A2 (hu) 2003-01-28
CN1394602A (zh) 2003-02-05
HK1049795A1 (zh) 2003-05-30
CA2391205A1 (en) 2002-12-28
SK8682002A3 (en) 2004-08-03
EP1270000A3 (en) 2003-02-12
JP2003034638A (ja) 2003-02-07
IL150340A0 (en) 2002-12-01
AU4239302A (en) 2003-01-02
EP1270000A2 (en) 2003-01-02
PL354770A1 (en) 2002-12-30
CZ20022076A3 (cs) 2004-05-12

Similar Documents

Publication Publication Date Title
BE2022C531I2 (cg-RX-API-DMAC7.html)
BE2022C547I2 (cg-RX-API-DMAC7.html)
BE2022C502I2 (cg-RX-API-DMAC7.html)
BE2017C059I2 (cg-RX-API-DMAC7.html)
BE2017C057I2 (cg-RX-API-DMAC7.html)
BE2017C051I2 (cg-RX-API-DMAC7.html)
BE2017C032I2 (cg-RX-API-DMAC7.html)
BE2016C051I2 (cg-RX-API-DMAC7.html)
BE2015C046I2 (cg-RX-API-DMAC7.html)
BE2014C052I2 (cg-RX-API-DMAC7.html)
BE2014C036I2 (cg-RX-API-DMAC7.html)
BE2014C026I2 (cg-RX-API-DMAC7.html)
BE2007C047I2 (cg-RX-API-DMAC7.html)
AU2002307149A8 (cg-RX-API-DMAC7.html)
BE2011C034I2 (cg-RX-API-DMAC7.html)
BE2014C006I2 (cg-RX-API-DMAC7.html)
BE2017C050I2 (cg-RX-API-DMAC7.html)
BRPI0204884B1 (cg-RX-API-DMAC7.html)
CH1379220H1 (cg-RX-API-DMAC7.html)
BRPI0101486B8 (cg-RX-API-DMAC7.html)
BE2012C051I2 (cg-RX-API-DMAC7.html)
BRPI0210463A2 (cg-RX-API-DMAC7.html)
JP2002082630A5 (cg-RX-API-DMAC7.html)
JP2002014934A5 (cg-RX-API-DMAC7.html)
BRMU8103221U (cg-RX-API-DMAC7.html)